2000
DOI: 10.1016/s0162-0134(00)00158-6
|View full text |Cite
|
Sign up to set email alerts
|

In vitro selection of aptamers that act with Zn2+

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
51
0

Year Published

2002
2002
2015
2015

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 86 publications
(51 citation statements)
references
References 27 publications
0
51
0
Order By: Relevance
“…In 1990, Szostak's group (Ellington and Szostak, 1990) and Gold's group (Tuerk and Gold, 1990) developed an in vitro aptamer selection process from random sequence pool. Aptamers bind to a wide range of targets, including metal ions (Kawakami et al, 2000), metabolites (Bruno et al, 2008), proteins (Ruckman et al, 1998;Savla et al, 2011), and whole organisms, such as viruses (Tang et al, 2009), bacteria (Hamula et al, 2011) and mammalian cells (Chen et al, 2009). Aptamers have advantages as recognition molecules.…”
Section: Introductionmentioning
confidence: 99%
“…In 1990, Szostak's group (Ellington and Szostak, 1990) and Gold's group (Tuerk and Gold, 1990) developed an in vitro aptamer selection process from random sequence pool. Aptamers bind to a wide range of targets, including metal ions (Kawakami et al, 2000), metabolites (Bruno et al, 2008), proteins (Ruckman et al, 1998;Savla et al, 2011), and whole organisms, such as viruses (Tang et al, 2009), bacteria (Hamula et al, 2011) and mammalian cells (Chen et al, 2009). Aptamers have advantages as recognition molecules.…”
Section: Introductionmentioning
confidence: 99%
“…G-quadruplex | systematic evolution of ligands by exponential enrichment | sensor | binding induced folding | molecular recognition N ucleic acid-based aptamers (1,2) can be selected in vitro against a wide range of targets (3)(4)(5)(6)(7)(8), chemically modified and synthetically produced, thereby making them a promising class of molecules for many applications including diagnostics (9,10), in vivo imaging (11,12), and targeted therapeutics (13,14). Unlike most conventional affinity reagents (e.g., antibodies), aptamers can also be engineered to perform complex molecular functions beyond binding.…”
mentioning
confidence: 99%
“…Aptamers are most commonly selected using a process known as systematic evolution of ligands by exponential enrichment (SELEX) [6], a screening technique involving the progressive selection of highly specific ligands from a large combinatorial nucleic acid library through repeated rounds of partition and amplification. Although aptamers for ions such as K 1 and Zn 21 and small molecules such as adenosine triphosphate (ATP) have been selected using SELEX [7,8], the processes are tedious and time-consuming. Due to the superior resolving power of CE, CE was demonstrated as an alternative SELEX selection procedure (CE-SELEX) [9].…”
Section: Introductionmentioning
confidence: 99%